|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 267.20 BDT | -1.11% |
|
-6.96% | -21.80% |
| Market Cap | 6.37B 51.56M 44.65M 41.63M 38.29M 72.28M 4.9B 73.08M 489M 192M 2.45B 194M 189M 8.12B | P/E 2024 |
231x | P/E 2025 | 182x |
|---|---|---|---|---|---|
| Enterprise Value | 6.67B 54M 46.77M 43.6M 40.1M 75.7M 5.13B 76.55M 512M 201M 2.57B 203M 198M 8.51B | EV / Sales 2024 |
12.2x | EV / Sales 2025 | 10.1x |
| Free-Float |
59.39% | Yield 2024 |
0.25% | Yield 2025 | 0.64% |
| 1 day | -1.11% | ||
| 1 week | -6.96% | ||
| Current month | -5.62% | ||
| 1 month | -13.33% | ||
| 3 months | -16.21% | ||
| 6 months | -26.21% | ||
| Current year | -21.80% |
| 1 week | 261.8 |  | 287 |
| 1 month | 261.8 | | 313 |
| Current year | 261.8 | | 391.8 |
| 1 year | 261.8 | | 587.5 |
| 3 years | 217.2 | | 726.9 |
| 5 years | 75 | | 1,000 |
| 10 years | 44 | | 1,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 2013-12-31 | |
| Director of Finance/CFO | - | 2020-11-07 | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2013-12-31 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 1983-05-04 |
| Director/Board Member | 45 | 1999-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.11% | -6.96% | -27.41% | -25.40% | 44.01M | |
| +3.93% | -4.53% | +50.82% | +154.40% | 995B | |
| +1.49% | -2.68% | +51.35% | +49.29% | 614B | |
| +0.70% | -6.89% | +23.48% | +63.08% | 431B | |
| +1.96% | +0.83% | +42.80% | +37.70% | 353B | |
| -0.11% | -4.07% | +30.37% | +38.52% | 293B | |
| +2.52% | -8.36% | +7.27% | +10.56% | 245B | |
| +3.75% | +4.35% | +34.80% | +59.92% | 210B | |
| -4.32% | -12.94% | -3.79% | -46.07% | 210B | |
| -3.60% | -1.73% | +15.98% | +61.69% | 168B | |
| Average | +0.57% | -5.15% | +22.57% | +40.37% | 351.83B | |
| Weighted average by Cap. | +1.66% | -5.89% | +36.15% | +71.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827M 6.69M 5.8M 5.4M 4.97M 9.38M 637M 9.49M 63.51M 24.93M 318M 25.14M 24.59M 1.05B | 665M 5.38M 4.66M 4.34M 3.99M 7.54M 512M 7.63M 51.04M 20.03M 256M 20.2M 19.76M 848M |
| Net income | 42.33M 343K 297K 277K 254K 480K 32.57M 485K 3.25M 1.28M 16.3M 1.29M 1.26M 53.97M | 35.02M 283K 245K 229K 210K 397K 26.94M 402K 2.69M 1.06M 13.48M 1.06M 1.04M 44.65M |
| Net Debt | 290M 2.35M 2.04M 1.9M 1.75M 3.29M 223M 3.33M 22.3M 8.75M 112M 8.83M 8.63M 370M | 302M 2.44M 2.12M 1.97M 1.82M 3.43M 232M 3.46M 23.19M 9.1M 116M 9.18M 8.98M 385M |
Employees
563
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | BDT 267.20 | -1.11% | 120,677 |
| 26-08-03 | BDT 270.20 | -0.63% | 353,728 |
| 26-08-02 | BDT 271.90 | -3.96% | 453,147 |
| 26-07-30 | BDT 283.10 | -0.77% | 139,690 |
| 26-07-29 | BDT 285.30 | -0.66% | 525,150 |
- Stock Market
- Stocks
- ORIONINFU Stock
Select your edition
All financial news and data tailored to specific country editions
